IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial
Li, C.2; Ni, J.3; Wang, Z.4; Li, M.5; Gasparic, M.6; Terhaag, B.1; Ueberall, M. A.7
关键词Flupirtine Tramadol Low back pain Subacute Disability Treatment
刊名CURRENT MEDICAL RESEARCH AND OPINION
2008-12-01
DOI10.1185/03007990802579769
24期:12页:3523-3530
收录类别SCI ; ISTP
文章类型Proceedings Paper
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal ; Medicine, Research & Experimental
研究领域[WOS]General & Internal Medicine ; Research & Experimental Medicine
关键词[WOS]PARALLEL-GROUP ; TITRATION RATE ; PREVALENCE ; DISABILITY ; 4-WEEK
英文摘要

Objective: To assess the efficacy and tolerability of flupirtine in comparison with tramadol for the treatment of moderate to severe subacute low back pain (LBP).

Design and methods: In this randomised, double-blind, parallel-group trial, 209 LBP patients, aged 18-65 years, were orally treated with flupirtine 100 mg (n=105) vs. tramadol 50 mg (n=104), both three times daily for 5-7days.

Main outcome measures: Patient assessment of pain intensity after 5-7 days (primary); physicians′ global assessment of improvement in pain and functional capacity; adverse events.

Results: Flupirtine showed an overall pain-relieving efficacy comparable to tramadol. Mean LBP intensity after end of treatment dropped from 6.8 (95% CI: 6.5-7.0) to 2.8 (95% CI: 2.3-3.1) for flupirtine and from 6.9 (95% CI: 6.6-7.1) to 3.0 (95% CI: 2.6-3.4) for tramadol, corresponding to pain relief rates of 57% (95% CI: 51-63%) and 56% (95% CI: 50-62%) respectively (p=0.796), indicating non-inferiority of flupirtine. All other efficacy endpoints supported equivalent efficacy. Adverse events (AEs) occurred significantly less in patients after flupirtine (33%) vs. tramadol (49%) (p=0.02) and both the respective severity grading and the AE-related dropout rates were significantly lower after flupirtine than after tramadol (1% vs. 15%, p<0.001).

Conclusion: Flupirtine 100 mg three times daily was associated with a reduction in pain and improvements in functional capacity equivalent to that observed with tramadol 50 mg three times daily, and was better tolerated, when administered to patients with subacute back pain for one week. The limitations of this study were the lack of a placebo control and the short (7-day) duration of the study.

语种英语
WOS记录号WOS:000262271400023
引用统计
被引频次:25[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65178
专题北京大学第一临床医学院
作者单位1.AWD Pharma GmbH & Co KG, D-01445 Radebeul, Germany
2.Beijing Univ, Hosp 1, Beijing 100871, Peoples R China
3.Capital Univ Med Sci, Xuanwu Hosp, Beijing, Peoples R China
4.Capital Univ Med Sci, Youyi Hosp, Beijing, Peoples R China
5.Pliva Pharmaceut, Zagreb, Croatia
6.Inst Qual Assurance Pain Therapy & Palliat Care, Nurnberg, Germany
7.Fourth Mil Med Univ, Xijing Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Li, C.,Ni, J.,Wang, Z.,et al. Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial[J]. CURRENT MEDICAL RESEARCH AND OPINION,2008,24(12):3523-3530.
APA Li, C..,Ni, J..,Wang, Z..,Li, M..,Gasparic, M..,...&Ueberall, M. A..(2008).Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial.CURRENT MEDICAL RESEARCH AND OPINION,24(12),3523-3530.
MLA Li, C.,et al."Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial".CURRENT MEDICAL RESEARCH AND OPINION 24.12(2008):3523-3530.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, C.]的文章
[Ni, J.]的文章
[Wang, Z.]的文章
百度学术
百度学术中相似的文章
[Li, C.]的文章
[Ni, J.]的文章
[Wang, Z.]的文章
必应学术
必应学术中相似的文章
[Li, C.]的文章
[Ni, J.]的文章
[Wang, Z.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。